Neurological symptoms are common in SGMS2-related skeletal disorders, particularly in severe cases, and include cranial nerve palsies, ataxia, reduced reflexes, and Alzheimer’s disease.2 This evidence concerns the gene SGMS2 and cerebellar ataxia.